clinical trial · NCT07414784
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
Healthy VolunteerABBV-295Levonorgestrel/Ethinyl Estradiol
brief summary
This Study of ABBV-295 subcutaneous injections will assess pharmacokinetics and adverse events in healthy adult women participants with overweight or obesity taking oral contraceptives.
started
Feb 11, 2026
primary completion
Jul 1, 2026
completion
Jul 1, 2026
last updated
Apr 27, 2026
official title
A Phase 1 Drug-Drug Interaction Study of ABBV-295, Levonorgestrel, and Ethinyl Estradiol in Healthy Adult Female Subjects With Overweight or Obesity
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol